ClinicalTrials.gg
Not yet recruitingNCT06712342Updated Dec 4, 2024

Effects of Upper Extremity-Focused Neuromuscular Training in People With Multiple Sclerosis

An interventional study of Neuromuscular Exercise Training and Conventional Exercise Training in Multiple Sclerosis, sponsored by Istanbul Aydın University. Not yet recruiting. Open to participants aged 18 Years to 64 Years. Per ClinicalTrials.gov, last updated 2024-12-04.

Sponsored by Istanbul Aydın University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by Nov 2025, 11 months ago, but the record still lists the study as not yet recruiting.
Phase
Not applicable
Study type
Interventional
Enrollment
72
Allocation
Randomized
Ages
18 Years to 64 Years
Sex
All
01

Study summary

The effectiveness of upper extremity focused neuromuscular exercise training in early stage people with MS will be investigated. People with MS enrolled in the study will be randomly assigned to three groups: Neuromuscular Exercise Group (NEG), Conventional Exercise Group (CEG), and Control Group (CG). All three groups will be assessed with primary and secondary outcome measures at baseline, week 8, and week 12. NEG, CEG, and CG will be initially assessed for upper extremity function, cognitive function, lower extremity function, grip strength, proximal muscle strength, sensation, coordination, fatigue, postural sway, and core muscle strength and endurance. Then, NEG will receive clinically supervised upper extremity focused neuromuscular exercise training with a minimum of 60 minutes of session time, 2 days a week for 8 weeks. This exercise training includes steps for postural control, weight transfer, proximal and distal muscle strengthening, proprioception, coordination and reaction speed. Similarly, CEG will receive clinically supervised traditional upper extremity exercise training, twice a week for 8 weeks, with a minimum of 60 minutes of session time. This exercise training includes strengthening with the band and manuel dexterity exercises. In both groups, stretching and mobility exercises will be added to the warm-up and cool-down exercises before and after the program. During this process, CG will be on the waiting list. At the end of 8 weeks, all three groups will be re-evaluated. After the exercise training, follow-up will be done and evaluations will be repeated in the 12th week. This study will provide evidence on the effects of upper extremity-focused neuromuscular exercise training on physical and cognitive functions in early-stage people with MS compared to traditional treatment approaches.

02

Conditions studied

  • Multiple Sclerosis

Keywords

  • Multiple Sclerosis
  • exercise
  • function
  • upper extremity
  • neuromuscular exercise training
  • manual dexterity
03

In context

Multiple Sclerosis

3,524 studies on the registry are indexed under Multiple Sclerosis; 668 are open to participants now.

This study's planned enrollment of 72 is above the median of 50 across 2,386 interventional studies indexed under Multiple Sclerosis.

Browse Multiple Sclerosis studies →

Lead sponsor

Istanbul Aydın University is the lead sponsor of 70 studies on the registry; 20 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 64 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Definite MS according to McDonald criteria,
  • 18-64 years
  • RRMS,
  • EDSS \< 4,
  • Minimal or moderate upper extremity involvement

Exclusion criteria

Exclusion Criteria:

  • Having an attack in the last three months,
  • Mini Mental Test \<24 or visual deficit,
  • Other medical conditions accompanying MS (cardiac, orthopedic or rheumatic, etc.),
  • Being pregnant or breastfeeding,
  • Doing regular exercise - receiving physiotherapy,
  • Having spasticity of 2 or more in the upper extremity
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
72 participants (estimated)

Study arms

  • Experimental
    NEG

    Upper Extremity Focused Neuromuscular Exercise Training

    Other: Neuromuscular Exercise Training

  • Active comparator
    CEG

    Traditional Upper Extremity Exercise Training

    Other: Conventional Exercise Training

  • No intervention
    CG

    Control Group

Interventions

  • OtherNeuromuscular Exercise Training

    This group will receive neuromuscular exercise training with 60-75 minute sessions per day, 2 days a week, for 8 weeks. Warm-up Program - 5 minutes Postural Control-Weight Transfer - 10-15 minutes Strength Training - 30-35 minutes Proprioception - Coordination - Reaction Speed 10-15 minutes Cool-down Program - 5 minutes

  • OtherConventional Exercise Training

    This group will be given traditional strength exercise training consisting of 60-75 minute sessions per day, 2 days per week for 8 weeks. Warm-up Program - 5 minutes Strength Training - 30-35 minutes Manuel Dexterity - 15-20 minutes Cool-down Program - 5 minutes

06

What researchers measure

Primary outcomes

  1. Nine Hole Peg Test

    To assess unilateral function of the upper extremity

    Time frame: At the beginning, at the end of 8 weeks and 12 weeks

  2. Minnesota Manual Dexterity Test

    To assess bilateral upper extremity function

    Time frame: At the beginning, at the end of 8 weeks and 12 weeks

  3. Manual Ability Measure-36

    To assess upper extremity function. A higher score indicates better hand function.

    Time frame: At the beginning, at the end of 8 weeks and 12 weeks

  4. Timed 25-Foot Walk

    To assess lower extremity function

    Time frame: At the beginning, at the end of 8 weeks and 12 weeks

  5. Symbol Digit Modalities Test

    To assess cognitive function

    Time frame: At the beginning, at the end of 8 weeks and 12 weeks

  6. Hand Dynamometer

    To assess hand grip strength

    Time frame: At the beginning, at the end of 8 weeks and 12 weeks

Secondary outcomes

  1. Hand Held Dynamometer

    To assess elbow muscle strength

    Time frame: At the beginning, at the end of 8 weeks and 12 weeks

  2. Biodex Balance System

    To assess postural sway

    Time frame: At the beginning, at the end of 8 weeks and 12 weeks

  3. Laser-pointer Assisted Angle Reproduction Test

    To assess of shoulder proprioception

    Time frame: At the beginning, at the end of 8 weeks and 12 weeks

  4. Finger Tapping Test

    To assess upper extremity coordination

    Time frame: At the beginning, at the end of 8 weeks and 12 weeks

  5. Fatigue Severity Scale

    To assess fatigue severity. A high score indicates high fatigue severity.

    Time frame: At the beginning, at the end of 8 weeks and 12 weeks

  6. Plank

    To assess core muscle endurance

    Time frame: At the beginning, at the end of 8 weeks and 12 weeks

  7. Curl-up

    To assess core muscle strength

    Time frame: At the beginning, at the end of 8 weeks and 12 weeks

07

Study locations

No study locations are listed for this record.

08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 4, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06712342
Lead sponsor
Istanbul Aydın University
Responsible party
Uğur OVACIK (PT, MSc, Istanbul Aydın University) — Principal investigator
First posted
Dec 2, 2024
Start date
Nov 30, 2024 (estimated)
Primary completion
Nov 1, 2025 (estimated)
Completion
Dec 29, 2025 (estimated)
Last update
Dec 4, 2024

Study contacts

Uğur Ovacık
Contact
ovacikugur@gmail.com
+90 444 1 428
Uğur Ovacık
principal investigator · Istanbul Aydın University
Ela Tarakcı
study director · Istanbul University - Cerrahpasa

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Dec 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion